A newly announced study backed by Takeda Pharmaceuticals, Lundbeck US, and Advocate Health Care will explore the effectiveness of a mobile app designed to improve engagement between patients with ...
After reaching the summit in a yearslong mission of introducing Takeda’s plasma-derived therapies (PDTs) to the market in its home country of Japan, Takeda team members started mapping out their next ...
Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, shares findings from a survey on colorectal cancer care inequities, and how to address these challenges. In the second part of this ...
Kim Newcomer, director of volunteers, Colorectal Cancer Alliance, discusses a study conducted with Takeda and the Harris Poll, focusing on the treatment experiences of patients with metastatic ...
A new survey from Takeda due to be presented at the ESMO Gastrointestinal Cancers Congress in Spain this week highlights major gaps in the treatment experiences of people with metastatic colorectal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results